Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
September 29, 2010
SYNOSIA PRESENTS DATA FROM CLINICAL TRIAL OF SYN-118 AS A NEW TREATMENT FOR PARKINSON’S DISEASE
September 22, 2010
SEMPRUS BIOSCIENCES AWARDED $500,000 NATIONAL SCIENCE FOUNDATION GRANT
September 9, 2010
ACHAOGEN TO PRESENT NEW DATA ON ACHN-490 AT THE 50TH ANNUAL ICAAC MEETING
August 30, 2010
ACHAOGEN AWARDED CONTRACT WORTH UP TO $64 MILLION BY BARDA FOR THE DEVELOPMENT OF ACHN-490
August 17, 2010
KALOBIOS, SEEKING TO APPLY ANTIBODIES BEYOND CANCER, SETS SIGHT ON KILLING DEADLY LUNG INVADER
August 12, 2010
VIVEVE-SPONSORED RESEARCH TO BE PUBLISHED IN JOURNAL OF SEXUAL MEDICINE
July 15, 2010
IKARIA® NAMES CHIEF SCIENCE OFFICER
July 13, 2010
VIVEVE-SPONSORED RESEARCH ACCEPTED FOR PRESENTATION AT TWO PRESTIGIOUS INTERNATIONAL CONFERENCES
July 8, 2010
IKARIA® NAMES NEW CHIEF FINANCIAL OFFICER
June 28, 2010
MARCADIA AND LILLY SIGN DEVELOPMENT, LICENSE AGREEMENT FOR NOVEL GLUCAGON PROGRAM IN SEVERE HYPOGLYCEMIA
« Previous Page
1
…
97
98
99
100
101
…
103